Baseline expression of numerous surface markers was comparable in untouched neutrophils from whole blood of SCLS patients and controls as assessed by flow cytometry, including granulocyte activation markers 31D8, CD63 and CD62L, β2‐integrins and Fc receptors (Figure S2). The gene discussed is SELL; the disease is capillary leak syndrome.